Press release
Develop business strategies Of Nasopharyngeal Cancer - Pipeline Review, H1 2018
About Nasopharyngeal Cancer Market
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasopharyngeal Cancer - Pipeline Review, H1 2018, provides an overview of the Nasopharyngeal Cancer (Oncology) pipeline landscape.
Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1581045
Nasopharyngeal cancer is a rare type of head and neck cancer. It starts in the upper part of throat, behind the nose. This area is called the nasopharynx. The risk factors of nasopharyngeal cancer may include Epstein-Barr virus. Symptoms of nasopharyngeal cancer may include blurry or double vision, difficulty speaking, including hoarseness, ear infections that keep coming back, face pain or numbness, headache, hearing loss, ringing in the ears. Treatment includes surgery, chemotherapy and radiation therapy.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Nasopharyngeal Cancer - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Nasopharyngeal Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Request for TOC @ https://www.marketresearchreports.biz/reports/1581045/nasopharyngeal-cancer-pipeline-review-h1-2018-market-research-reports/toc
The Nasopharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Nasopharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 3, 15, 12, 7, 4 and 1 respectively. Similarly, the Universities portfolio in Phase II, Phase I and Preclinical stages comprises 6, 3 and 6 molecules, respectively.
Nasopharyngeal Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Nasopharyngeal Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Nasopharyngeal Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Nasopharyngeal Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Nasopharyngeal Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Nasopharyngeal Cancer (Oncology)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Nasopharyngeal Cancer (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Nasopharyngeal Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
View Report @ https://www.marketresearchreports.biz/reports/1581045/nasopharyngeal-cancer-pipeline-review-h1-2018-market-research-reports
Table of Contents
Table of Contents 2
Introduction 4
Nasopharyngeal Cancer - Overview 5
Nasopharyngeal Cancer - Therapeutics Development 6
Nasopharyngeal Cancer - Therapeutics Assessment 15
Nasopharyngeal Cancer - Companies Involved in Therapeutics Development 25
Nasopharyngeal Cancer - Drug Profiles 39
Nasopharyngeal Cancer - Dormant Projects 353
Nasopharyngeal Cancer - Discontinued Products 355
Nasopharyngeal Cancer - Product Development Milestones 356
Appendix 363
List of Tables
Number of Products under Development for Nasopharyngeal Cancer, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Products under Development by Companies, H1 2018
Products under Development by Universities/Institutes, H1 2018
Number of Products by Stage and Target, H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018
Number of Products by Stage and Route of Administration, H1 2018
Number of Products by Stage and Molecule Type, H1 2018
Nasopharyngeal Cancer - Pipeline by Advenchen Laboratories LLC, H1 2018
Nasopharyngeal Cancer - Pipeline by Ambrx Inc, H1 2018
Nasopharyngeal Cancer - Pipeline by arGEN-X BV, H1 2018
Nasopharyngeal Cancer - Pipeline by Ascentage Pharma Group Corp Ltd, H1 2018
Nasopharyngeal Cancer - Pipeline by Atara Biotherapeutics Inc, H1 2018
Nasopharyngeal Cancer - Pipeline by AVEO Pharmaceuticals Inc, H1 2018
Nasopharyngeal Cancer - Pipeline by BeiGene Ltd, H1 2018
Nasopharyngeal Cancer - Pipeline by BioDiem Ltd, H1 2018
Nasopharyngeal Cancer - Pipeline by Biomics Biotechnologies Co Ltd, H1 2018
Nasopharyngeal Cancer - Pipeline by Bristol-Myers Squibb Co, H1 2018
Nasopharyngeal Cancer - Pipeline by CBT Pharmaceuticals Inc, H1 2018
Nasopharyngeal Cancer - Pipeline by Celgene Corp, H1 2018
Nasopharyngeal Cancer - Pipeline by Cell Medica Ltd, H1 2018
Nasopharyngeal Cancer - Pipeline by F. Hoffmann-La Roche Ltd, H1 2018
Nasopharyngeal Cancer - Pipeline by GlaxoSmithKline Plc, H1 2018
Nasopharyngeal Cancer - Pipeline by Incyte Corp, H1 2018
Nasopharyngeal Cancer - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H1 2018
Nasopharyngeal Cancer - Pipeline by MedImmune LLC, H1 2018
Nasopharyngeal Cancer - Pipeline by Merck & Co Inc, H1 2018
Nasopharyngeal Cancer - Pipeline by Merck KGaA, H1 2018
Nasopharyngeal Cancer - Pipeline by Millennium Pharmaceuticals Inc, H1 2018
Nasopharyngeal Cancer - Pipeline by Molecular Partners AG, H1 2018
Nasopharyngeal Cancer - Pipeline by Neonc Technologies Inc, H1 2018
Nasopharyngeal Cancer - Pipeline by Novartis AG, H1 2018
Nasopharyngeal Cancer - Pipeline by Ono Pharmaceutical Co Ltd, H1 2018
Nasopharyngeal Cancer - Pipeline by Otsuka Holdings Co Ltd, H1 2018
Nasopharyngeal Cancer - Pipeline by Systimmune Inc, H1 2018
Nasopharyngeal Cancer - Pipeline by Tessa Therapeutics Pte Ltd, H1 2018
Nasopharyngeal Cancer - Pipeline by Vectorite Biomedical Inc, H1 2018
Nasopharyngeal Cancer - Pipeline by Viracta Therapeutics Inc, H1 2018
Nasopharyngeal Cancer - Dormant Projects, H1 2018
Nasopharyngeal Cancer - Discontinued Products, H1 2018
Buy Now @ https://www.researchmoz.com/checkout?rep_id=1581045&licType=S
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Develop business strategies Of Nasopharyngeal Cancer - Pipeline Review, H1 2018 here
News-ID: 955873 • Views: …
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for Nasopharyngeal
Nasopharyngeal Swabs Market Size Unlocking New Opportunities for Success
The global nasopharyngeal swabs market was valued at approximately USD 296.8 million in 2023 and is projected to reach USD 404.1 million by 2032, growing at a compound annual growth rate (CAGR) of 6.3% from 2024 to 2032.
Request a sample copy of this report at: https://www.omrglobal.com/request-sample/nasopharyngeal-swabs-market
Nasopharyngeal Swabs Market Overview:
The nasopharyngeal swabs market is experiencing significant growth due to the increasing demand for accurate diagnostic tools in the healthcare sector. These…
Nasopharyngeal Carcinoma Treatment Market Outlook 2024: Innovations and Forecast
"The Business Research Company recently released a comprehensive report on the Global Nasopharyngeal Carcinoma Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The nasopharyngeal carcinoma…
Nasopharyngeal Airway Market Size 2024 to 2031.
Market Overview and Report Coverage
A nasopharyngeal airway (NPA) is a medical device used to maintain an open airway in patients who are unconscious or unable to protect their own airway. It is commonly used in emergency medical situations, such as during resuscitation or in the management of patients with trauma or airway obstructions.
The current outlook for the nasopharyngeal airway market is positive, with a projected growth rate of…
Nasopharyngeal Carcinoma Treatment Market
The latest Report Available at USD Analytics Market, "Nasopharyngeal Carcinoma Treatment Market" provides a pin-point analysis of changing competitive dynamics and a forward-looking perspective on different factors driving or restraining industry growth.
As the Political, Economic, Social, Technological, Environmental, and Legal factors continue to change, business leaders across industries have shifted focus to strategic objectives to achieve market excellence. The "Global Nasopharyngeal Carcinoma Treatment Market Size, Share Analysis with Forecast to…
Nasopharyngeal Carcinoma Treatment Market Size, Share, Outlook 2026
Nasopharyngeal carcinoma is a rare cancer, affecting the part of throat connecting nose and mouth, known as pharynx. Nasopharyngeal carcinoma are of three types, based on cell appearance under microscope. These include keratinizing squamous cell carcinoma, non- keratinizing differentiated carcinoma, and undifferentiated carcinoma. The early stage symptoms of nasopharyngeal carcinoma are bleeding nose, blockage and stuffiness in nose, persistent ear infection, hearing difficulties, and sore throat whereas, late stage symptoms…
Nasopharyngeal Cancer Market Estimated to Grow Strongly by 2022
Nasopharyngeal is a type of cancer which takes place in head or neck. It happens in nasopharynx, which is a upper part of the of the throat behind the nose. It is also called nasopharyngeal carcinoma (NPC). It has also been linked with Epstein-Barr virus.
Get access to full summary @: http://www.persistencemarketresearch.com/market-research/nasopharyngeal-cancer-market.asp
In 2015, American Society of Clinical Oncology (ASCO) estimated 3200 to be diagnosed with NPC in U.S. The prevalence rate…
